AKTX

Akari Therapeutics, Plc

NasdaqCMUSDEQUITY DELAYED

7.69

▼ 0.10 (1.28%)

MARKET · —

Price

Open

7.70

Prev close

7.79

Day high

8.10

Day low

7.77

Volume

10.73K

Market cap

—

P/E (TTM)

—

52W range

3.02 – 49.60

Trailing performance

Price return · vs SPY

Returnvs SPY

+4.11% +5.5%

-15.59% -19.3%

+52.72% +49.6%

-17.19% -28.3%

YTD

-32.09% -44.4%

-79.34% -99.3%

-94.81% -169.0%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

7.59

+1.27% from price

SMA 20

7.73

+1.51% from price

SMA 50

10.07

-22.03% from price

SMA 100

8.92

-13.79% from price

SMA 200

10.63

-26.18% from price

EMA 12

7.79

-1.26% from price

EMA 26

8.45

-8.97% from price

EMA 50

9.16

-16.09% from price

RSI (14)

44.1

Neutral

MACD (12,26,9)

-0.66

Hist 0.18

ATR (14)

0.74

9.38% of price

Realised vol 30D

88.8%

Annualised

Bollinger upper

8.54

20, 2σ

Bollinger lower

6.93

20, 2σ

50 / 200 cross

Death

10.07 vs 10.63

Trend bias

Below 200

-26.18%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.78

More volatile than market

Correlation to SPY

0.08

Largely independent

Realised vol 30D

88.8%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-93.2%

Peak to trough

Max drawdown 5Y

-99.8%

Peak to trough

ATR 14

0.74

9.38% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 7.69

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

AKTX · links out to the publisher

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading MT Newswires · 4d ago Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy GlobeNewswire · 4d ago European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading MT Newswires · 5d ago European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading MT Newswires · 8d ago Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform GlobeNewswire · 9d ago European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading MT Newswires · 11d ago European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading MT Newswires · 12d ago European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading MT Newswires · 15d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.